These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33195136)

  • 21. Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; del Campo L; Andrés V
    Annu Rev Physiol; 2018 Feb; 80():27-48. PubMed ID: 28934587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
    Lo Cicero A; Nissan X
    Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
    Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
    Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
    Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
    Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
    Brassard JA; Fekete N; Garnier A; Hoesli CA
    Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome.
    Wu Z; Zhang W; Song M; Wang W; Wei G; Li W; Lei J; Huang Y; Sang Y; Chan P; Chen C; Qu J; Suzuki K; Belmonte JCI; Liu GH
    Protein Cell; 2018 Apr; 9(4):333-350. PubMed ID: 29476423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.
    Harhouri K; Frankel D; Bartoli C; Roll P; De Sandre-Giovannoli A; Lévy N
    Nucleus; 2018 Jan; 9(1):246-257. PubMed ID: 29619863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome.
    Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA
    Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
    Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
    Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
    Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
    Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
    Lee JM; Nobumori C; Tu Y; Choi C; Yang SH; Jung HJ; Vickers TA; Rigo F; Bennett CF; Young SG; Fong LG
    J Clin Invest; 2016 Apr; 126(4):1592-602. PubMed ID: 26999604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
    Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
    J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hutchinson-Gilford Progeria Syndrome-Current Status and Prospects for Gene Therapy Treatment.
    Piekarowicz K; Machowska M; Dzianisava V; Rzepecki R
    Cells; 2019 Jan; 8(2):. PubMed ID: 30691039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
    Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
    BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells derived from patients with premature aging syndromes display hallmarks of physiological aging.
    Trani JP; Chevalier R; Caron L; El Yazidi C; Broucqsault N; Toury L; Thomas M; Annab K; Binetruy B; De Sandre-Giovannoli A; Levy N; Magdinier F; Robin JD
    Life Sci Alliance; 2022 Sep; 5(12):. PubMed ID: 36104080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome?
    Del Campo L; Hamczyk MR; Andrés V; Martínez-González J; Rodríguez C;
    Clin Investig Arterioscler; 2018; 30(3):120-132. PubMed ID: 29602596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.
    Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A
    Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells.
    Cao K; Capell BC; Erdos MR; Djabali K; Collins FS
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4949-54. PubMed ID: 17360355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
    Gonzalo S; Kreienkamp R; Askjaer P
    Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation.
    Gordon LB; Norris W; Hamren S; Goodson R; LeClair J; Massaro J; Lyass A; D'Agostino RB; Tuminelli K; Kieran MW; Kleinman ME
    Circulation; 2023 Jun; 147(23):1734-1744. PubMed ID: 36919608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.